Strategic Neuroscience Clinical Development Consulting
Global Phase I–III CNS Programs
Accelerating development. Optimising endpoints. Reducing risk in complex neuroscience clinical trials.
Discuss Your Program
What I Do
Core Capabilities Snapshot
Senior-level clinical development support across the most demanding stages of CNS programs.
Strategy & Endpoints
- Clinical Development Strategy
- Endpoint & COA/eCOA Optimisation
- Protocol Design & Eligibility Review
- Placebo Mitigation Strategy
Governance & Quality
- Governance & Sponsor–CRO Leadership
- Rater Qualification & Training Frameworks
- Risk Assessment & Mitigation Planning
- Data Quality & Endpoint Trend Analysis
Who I Work With
Trusted by Sponsors, CROs and Investors
Specialist support for the teams driving the next generation of CNS therapies.
Emerging & mid-size biotech sponsors
Venture-backed CNS companies
CROs requiring senior expertise
Programs preparing for Phase II/III
Sponsors facing endpoint challenges
Ready to Strengthen Your CNS Program?
Senior strategic input, scientific rigour and operational realism — on demand.